{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:26:40Z","timestamp":1791480400686,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhandsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Hand Surgery"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jhsa.2025.08.004","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T22:29:20Z","timestamp":1759789760000},"page":"1297-1303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Glucagon-like peptide-1 Agonists and Common Hand Procedures: Perioperative and Postoperative Risks and Complications"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0792-9739","authenticated-orcid":false,"given":"Troy B.","family":"Amen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina I.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Gillinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh A.","family":"Torabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Liimakka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jhsa.2025.08.004_bib6","first-page":"S158","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhsa.2025.08.004_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d7771","article-title":"Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials","volume":"344","author":"Vilsb\u00f8ll","year":"2012","journal-title":"BMJ"},{"issue":"17","key":"10.1016\/j.jhsa.2025.08.004_bib8","doi-asserted-by":"crossref","first-page":"9351","DOI":"10.3390\/ijms25179351","article-title":"Mechanistic pathways and clinical implications of GLP-1 receptor agonists in type 1 diabetes management","volume":"25","author":"Delrue","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"Supplement 1","key":"10.1016\/j.jhsa.2025.08.004_bib10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1182\/blood-2024-206409","article-title":"Glucagon-like peptide 1 receptor agonists reduce the risk of venous thromboembolism in patients with diabetes irrespective of obesity: a propensity score-matched multicenter database analysis","volume":"144","author":"Chiang","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jhsa.2025.08.004_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3094642","article-title":"Anti-inflammatory Effects of GLP-1-based therapies beyond glucose control","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediators Inflamm"},{"issue":"19","key":"10.1016\/j.jhsa.2025.08.004_bib12","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1001\/jama.2024.5003","article-title":"Preoperative GLP-1 receptor agonist use and risk of postoperative respiratory complications","volume":"331","author":"Dixit","year":"2024","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jhsa.2025.08.004_bib13","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/ALN.0000000000005231","article-title":"Preprocedure care of patients on glucagon-like peptide-1 receptor agonists: a multisociety clinical practice guidance","volume":"141","author":"Joshi","year":"2024","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jhsa.2025.08.004_bib35","article-title":"Impact of glucagon-like peptide-1 receptor agonists on postoperative outcomes in arthroplasty: a systematic review","author":"Lee","year":"2025","journal-title":"J Arthroplasty"},{"issue":"9","key":"10.1016\/j.jhsa.2025.08.004_bib14","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1007\/s11999-014-3686-7","article-title":"The Elixhauser comorbidity method outperforms the Charlson index in predicting inpatient death after orthopaedic surgery","volume":"472","author":"Menendez","year":"2014","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jhsa.2025.08.004_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcot.2020.12.001","article-title":"Differences in the predictive value of Elixhauser Comorbidity Index and the Charlson comorbidity indices in patients with hand infections","volume":"16","author":"Congiusta","year":"2021","journal-title":"J Clin Orthop Trauma"},{"issue":"4","key":"10.1016\/j.jhsa.2025.08.004_bib16","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jse.2024.07.045","article-title":"Does use of GLP-1 agonists increase postoperative complications in patients undergoing shoulder arthroplasty?","volume":"34","author":"Elsabbagh","year":"2025","journal-title":"J Shoulder Elbow Surg"},{"issue":"5","key":"10.1016\/j.jhsa.2025.08.004_bib17","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jse.2024.09.012","article-title":"Glucagon-like peptide-1 receptor agonist use is associated with increased risk of perioperative complication and readmission following shoulder arthroplasty","volume":"34","author":"Lawand","year":"2025","journal-title":"J Shoulder Elbow Surg"},{"issue":"12","key":"10.1016\/j.jhsa.2025.08.004_bib18","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/j.arth.2024.05.079","article-title":"Decreased risk of readmission and complications with preoperative GLP-1 analog use in patients undergoing primary total joint arthroplasty","volume":"39","author":"Buddhiraju","year":"2024","journal-title":"J Arthroplasty"},{"issue":"11","key":"10.1016\/j.jhsa.2025.08.004_bib19","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.arth.2023.05.071","article-title":"Does semaglutide use decrease complications and costs following total knee arthroplasty?","volume":"38","author":"Magruder","year":"2023","journal-title":"J Arthroplasty"},{"issue":"3","key":"10.1016\/j.jhsa.2025.08.004_bib20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.arth.2023.12.023","article-title":"Semaglutide use prior to total hip arthroplasty results in fewer postoperative prosthetic joint infections and readmissions","volume":"39","author":"Magruder","year":"2024","journal-title":"J Arthroplasty"},{"issue":"2","key":"10.1016\/j.jhsa.2025.08.004_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.arthro.2024.09.057","article-title":"Lower risk of postoperative complications and rotator cuff retear associated with semaglutide use in patients with type II diabetes mellitus undergoing arthroscopic rotator cuff repair","volume":"41","author":"Seddio","year":"2025","journal-title":"Arthroscopy"},{"issue":"3","key":"10.1016\/j.jhsa.2025.08.004_bib22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.spinee.2024.10.011","article-title":"Semaglutide utilization associated with reduced 90-day postoperative complications following single-level posterior lumbar fusion for patients with type II diabetes","volume":"25","author":"Seddio","year":"2025","journal-title":"Spine J"},{"issue":"6","key":"10.1016\/j.jhsa.2025.08.004_bib23","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jhsg.2023.07.012","article-title":"The effect of body mass index on open carpal tunnel release recovery","volume":"5","author":"Allen","year":"2023","journal-title":"J Hand Surg Glob Online"},{"issue":"2","key":"10.1016\/j.jhsa.2025.08.004_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jhsa.2017.11.003","article-title":"Quantifying the effect of diabetes on surgical hand and forearm infections","volume":"43","author":"Sharma","year":"2018","journal-title":"J Hand Surg Am"},{"issue":"9","key":"10.1016\/j.jhsa.2025.08.004_bib25","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1016\/j.arth.2021.04.017","article-title":"Effects of the obesity epidemic on total hip and knee arthroplasty demographics","volume":"36","author":"Johnson","year":"2021","journal-title":"J Arthroplasty"},{"issue":"10016","key":"10.1016\/j.jhsa.2025.08.004_bib26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0140-6736(14)61798-0","article-title":"Periprosthetic joint infection","volume":"387","author":"Kapadia","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jhsa.2025.08.004_bib27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/iwj.12640","article-title":"Risk factors for periprosthetic joint infection following primary total hip or knee arthroplasty: a meta-analysis","volume":"14","author":"Kong","year":"2017","journal-title":"Int Wound J"},{"issue":"3","key":"10.1016\/j.jhsa.2025.08.004_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMra2203477","article-title":"Periprosthetic joint infection","volume":"388","author":"Patel","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jhsa.2025.08.004_bib29","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.bja.2024.01.001","article-title":"Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration","volume":"132","author":"van Zuylen","year":"2024","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.jhsa.2025.08.004_bib30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2024.03.015","article-title":"Increased risk of aspiration pneumonia associated with endoscopic procedures among patients with glucagon-like peptide 1 receptor agonist use","volume":"167","author":"Yeo","year":"2024","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1016\/j.jhsa.2025.08.004_bib31","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.3390\/jcm13216336","article-title":"A scoping review of GLP-1 receptor agonists: are they associated with increased gastric contents, regurgitation, and aspiration events?","volume":"13","author":"Chang","year":"2024","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.jhsa.2025.08.004_bib32","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S2468-1253(24)00188-2","article-title":"Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions","volume":"9","author":"Jalleh","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhsa.2025.08.004_bib33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/ACO.0000000000001348","article-title":"Perioperative management of patients on glucagon-like peptide-1 receptor agonists","volume":"37","author":"Mizubuti","year":"2024","journal-title":"Curr Opin Anaesthesiol"}],"container-title":["The Journal of Hand Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363502325004423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363502325004423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:21:56Z","timestamp":1762543316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0363502325004423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0363502325004423"],"URL":"https:\/\/doi.org\/10.1016\/j.jhsa.2025.08.004","relation":{},"ISSN":["0363-5023"],"issn-type":[{"value":"0363-5023","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide-1 Agonists and Common Hand Procedures: Perioperative and Postoperative Risks and Complications","name":"articletitle","label":"Article Title"},{"value":"The Journal of Hand Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhsa.2025.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Society for Surgery of the Hand. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}